孕期野百合碱暴露对大鼠胎盘的损伤作用及其代谢机制

中国药物警戒 ›› 2019, Vol. 16 ›› Issue (2): 65-70.

• 吡咯里西啶生物碱的发育毒性专栏 • 下一篇

孕期野百合碱暴露对大鼠胎盘的损伤作用及其代谢机制

刘杰^1,2, 杨晓静³, 郑江³, 王艳清⁴, 向娥^1,2, 汪晖^1,2, 郭喻^1,2,*

1 武汉大学基础医学院药理学系,湖北武汉 430071;
2 发育源性疾病湖北省重点实验室,湖北武汉 430071;
3 沈阳药科大学药学院,辽宁沈阳 110000;
4 武汉大学人民医院妇产科,湖北武汉 430060

收稿日期:2019-03-12 修回日期:2019-03-12 出版日期:2019-02-25 发布日期:2019-03-12
作者简介:刘杰,男,在读硕士,药理学。

Effects of Exposure to Monocrotaline on Placental Damage and Its Mechanism in Rats

LIU Jie^1,2, YANG Xiaojing³, ZHENG Jiang³, WANG Yanqing⁴, XIANG E^1,2, WANG Hui^1,2, GUO Yu^1,2,*

1 Department of Pharmacology, Basic Medical School of Wuhan University, Hubei Wuhan 430071, China;
2 Hubei Provincial Key Laboratory of Developmentally Originated Disease, Hubei Wuhan 430071, China;
3 School of Pharmacy, Shenyang Pharmaceutical University, Liaoning Shenyang 110016, China;
4 Department of Gynecology, Renming Hospital of Wuhan University, Hubei Wuhan 430060, China

Received:2019-03-12 Revised:2019-03-12 Online:2019-02-25 Published:2019-03-12
Contact: *郭喻,女,副教授,发育毒理学。E-mail：guoy@whu.edu.cn
Supported by:
国家自然科学基金（81473290）：吡咯里西啶生物碱致母、胎肝毒性差异及其代谢活化机制; 国家自然科学基金青年项目（30901835）：胎肾上腺CYP3A介导吡咯双环生物碱类发育毒性的代谢损伤机制; 中央高校基本科研业务费专项（2042017Kf1032）：吡咯里西啶生物碱致发育毒性的性别差异及其机制研究

摘要/Abstract

摘要： 目的探讨孕期野百合碱（monocrotaline,MCT）暴露对胎盘的损伤作用及其发生机制。方法 Wistar孕鼠分为给药组和对照组,在妊娠第9天至20天（gestation day,GD）灌胃给予20 mg·kg-1 MCT,对照组给予等体积的溶剂处理。在GD 20给药2 h后麻醉处死大鼠,并取母肝及胎盘。观察胎盘重量和形态学改变,分别检测母肝、胎盘中吡咯代谢产物与蛋白结合物（pyrrole-protein adducts,PPAs）的含量,同时检测母肝及胎盘细胞色素P450（cytochrome P450,CYP）3A的基础表达和MCT暴露后表达水平,并确定了胎盘有机阳离子转运体3（organic cation transporter 3,OCT3）和P-糖蛋白（P-glycoprotein,P-gp）的表达变化。结果与对照组相比,孕期MCT处理大鼠胎盘重量显著降低,并伴有胎盘形态结构的损伤。胎盘的CYP3A基础表达远低于母肝,但MCT暴露后,胎盘PPAs含量几乎与母肝一致。与对照组相比,MCT暴露组胎盘的CYP3A1和OCT3表达无显著变化,而P-gp的表达显著增加。结论孕期MCT暴露可造成胎盘损伤,母肝代谢产生的活性吡咯代谢产物可能是造成胎盘损伤的主要原因。

关键词: 野百合碱, 胎盘, 细胞色素P450 3A, 转运体

Abstract: Objective To investigate the effects of exposure to monocrotaline (MCT) on placental damage and its mechanism. Methods Pregnant Wistar rats were divided into control and MCT groups. The rats in MCT group were intragastrically given 20 mg·kg-1 MCT daily from gestation day (GD) 9 to 20, and the control group was given the same volume of solvent. After 2 h of the last administration in GD 20, the rats were anesthetized and executed, and the maternal livers and placentae were collected. The placental weight and morphology was observed. The contents of pyrrole-protein adducts (PPAs) in placenta and mother liver were measured using HPLC-MS. Expression of cytochrome P450 (CYP) 3A and transporters in placenta were also determined. Results Compared with the control group, the placental weight was decreased significantly in the rats treated with MCT during pregnancy, accompanied with an obvious morphological change in placenta structure. The basal expression of CYP3A in placenta was lower than that in maternal liver, while the content of PPAs in placenta was almost equal to that in maternal liver. In addition, there was no significant change in placental expression of CYP3A or organic cation transporter 3. But expression of P-glycoprotein in placenta was increased by MCT exposure. Conclusion Prenatal exposure to MCT caused placenta damage, which may be due to the active pyrrole metabolites generated by maternal liver.

Key words: monocrotaline, placenta, cytochrome P450 3A, transporter

中图分类号:

R961

刘杰, 杨晓静, 郑江, 王艳清, 向娥, 汪晖, 郭喻. 孕期野百合碱暴露对大鼠胎盘的损伤作用及其代谢机制[J]. 中国药物警戒, 2019, 16(2): 65-70.

LIU Jie, YANG Xiaojing, ZHENG Jiang, WANG Yanqing, XIANG E, WANG Hui, GUO Yu. Effects of Exposure to Monocrotaline on Placental Damage and Its Mechanism in Rats[J]. Chinese Journal of Pharmacovigilance, 2019, 16(2): 65-70.

参考文献

[1] Fu P P, Xia Q, Lin G, et al.Pyrrolizidine Alkaloids-Genotoxicity, Metabolism Enzymes, Metabolic Activation, and Mechanisms[J]. Drug Metabolism Reviews, 2004, 36(1):1-55.
[2] Yang Y C, Crowder J, Wardle N J, et al.1H NMR study of monocrotaline and its metabolites in human blood[J]. Food Chem Toxicol., 2011,49(11):2793-2799.
[3] The China Pharmacopoeia Committee. Pharmacopoeia of the People's Republic of China(in Chinese)[S]. 2015ed. Beijing: China Medical Science Press, 2015.
[4] Ruan J, Yang M, Fu P, et al.Metabolic Activation of Pyrrolizidine Alkaloids: Insights into the Structural and Enzymatic Basis[J]. Chem Res Toxicol., 2014,27(16):1030-1039.
[5] Lu Y, Ma J, Song Z, et al.The role of formation of pyrrole-ATP synthase subunit beta adduct in pyrrolizidine alkaloid-induced hepatotoxicity[J]. Archives of Toxicology, 2018,92(11):3403-3414.
[6] Kolrep F, Numata J, Kneuer C, et al.In vitro biotransformation of pyrrolizidine alkaloids in different species. Part I: Microsomal degradation[J]. Archives of Toxicology, 2018,92(3):1089-1097.
[7] Li X, Yang X, Xiang E, et al.Maternal-Fetal Disposition and Metabolism of Retrorsine in Pregnant Rats[J]. Drug Metabolism and Disposition, 2018, 46(4):422-428.
[8] Guo Y, Ma Z, Kou H, et al.Synergistic effects of pyrrolizidine alkaloids and lipopolysaccharide on preterm delivery and intrauterine fetal death in mice[J]. Toxicology Letters, 2013, 221(3):212-218.
[9] Kalisch-Smith J I, Simmons D G, Dickinson H, et al. Review: Sexual dimorphism in the formation, function and adaptation of the placenta[J]. Placenta, 2017,54:10-16.
[10] Mattocks A R, Legg R F, Jukes R.Trapping of short-lived electrophilic metabolites of pyrrolizidine alkaloids escaping from perfused rat liver[J]. Toxicology Letters, 1990, 54(1):93-99.
[11] Cooper R A, Huxtable R J.The relationship between reactivity of metabolites of pyrrolizidine alkaloids and extrahepatic toxicity[J]. Proceedings of the Western Pharmacology Society, 1999, 42:13-16.
[12] Hakkola J, Pasanen M, Hukkanen J, et al.Expression of xenobiotic-metabolizing cytochrome P450 Forms in human full-term placenta[J]. Biochemical Pharmacology, 1996, 51(4):403-411.
[13] Staud F, Cerveny L, Ceckova M.Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure[J]. Journal of Drug Targeting, 20(9):736-763.
[14] Tu M, Li L, Lei H, et al.Involvement of organic cation transporter 1 and CYP3A4 in retrorsine-induced toxicity[J]. Toxicology, 2014, 322:34-42.
[15] Hessel S, Gottschalk C, Schumann D, et al.Structure-activity relationship in the passage of different pyrrolizidine alkaloids through the gastrointestinal barrier: ABCB1 excretes heliotrine and echimidine[J]. Molecular Nutrition & Food Research, 2014, 58(5):995-1004.
[16] Longo L D, Reynolds L P.Some historical aspects of understanding placental development, structure and function[J]. International Journal of Developmental Biology, 2010,54(2-3):237-55.
[17] DuyguIskenderMazman, Zuhal Akçören, Şule Yiğit, et al. Placental findings of IUGR and non-IUGR[J]. Turk J Pediatr, 2014, 56(4):368-373.
[18] Medeiros R M T, Silvana L. Górniak, José Luis Guerra. Fetotoxicity and reproductive effects of monocrotaline in pregnant rats[J]. Journal of Ethnopharmacology, 2000, 69(2):181-188.
[19] Orhan H.Extrahepatic targets and cellular reactivity of drug metabolites[J]. Curr Med Chem, 2015,22(4):408-437.
[20] Lee N, Hebert M F, Prasad B, et al.Effect of Gestational Age on mRNA and Protein Expression of Polyspecific Organic Cation Transporters during Pregnancy[J]. Drug Metabolism and Disposition, 2013, 41(12):2225-2232.

孕期野百合碱暴露对大鼠胎盘的损伤作用及其代谢机制

Effects of Exposure to Monocrotaline on Placental Damage and Its Mechanism in Rats

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 6

编辑推荐

Metrics

[1]	李玥, 张爽, 孙鑫, 刘成海, 裘福荣. 野百合碱致肝窦阻塞综合征与中性粒细胞胞外诱捕网的关联性研究[J]. 中国药物警戒, 2023, 20(2): 121-126.
[2]	汪祺, 杨建波, 王莹, 马双成, 文海若. 基于转运体探讨何首乌提取物对大鼠肾脏的影响[J]. 中国药物警戒, 2022, 19(6): 626-629.
[3]	昝珂, 周颖, 李耀磊, 王莹, 金红宇, 左甜甜, 马双成. 赤小豆中吡咯里西啶生物碱氮氧化物含量测定及安全风险评估[J]. 中国药物警戒, 2022, 19(11): 1186-1190.
[4]	王姝廷, 邱彩霞, 王凤林, 靳洪涛. 代谢酶和转运体介导的草药-化学药相互作用安全性研究进展[J]. 中国药物警戒, 2021, 18(1): 18-23.
[5]	郭麒, 王艳清, 程艳香, 刘杰, 邱帅凯, 向娥, 汪晖, 郭喻. 孕期野百合碱暴露对胎鼠胆固醇水平的影响[J]. 中国药物警戒, 2019, 16(2): 71-75.
[6]	宋蕾, 王琴, 毕亚男, 史红, 张玥, 周昆. 何首乌4种单体成分灌胃14天的小鼠肝肾毒性研究[J]. 中国药物警戒, 2018, 15(9): 513-517.